Physician

Thomas Lewis Hamaguchi Hocker, M.D.

According to 2025 Medicare claims, Thomas Hocker, M.D. (NPI: 1689841025) practices pathology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is ADVANCED DERMATOLOGIC SURGERY, P.A. (NPI: 1003016312; TIN: 481179538) and primary practice location at 66209-2007. Hocker is affiliated with the Centrus Health LLC (ACO ID: A5304) and Centrus Health of Kansas LLC (ACO ID: A5305), participating under the MSSP model.

Hocker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,312 traditional Medicare patients, billed 5,452 HCPCS/CPT codes, and received $1,159,921 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,770 prescription claims across 1,303 beneficiaries totaling $25,545 in drug costs, led by Doxycycline Hyclate (Doxycycline Hyclate). Open Payments data shows 1 records totaling $23. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $385,491 to $1,159,921. Similarly, Part D prescription costs have moved sharply higher in recent years, from $10,913 to $25,545. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	435	2,391	$385,491
2016	532	3,014	$471,434
2017	673	3,615	$584,633
2018	721	3,447	$658,174
2019	832	4,062	$872,148
2020	1,173	5,913	$1,312,260
2021	1,311	5,416	$1,449,830
2022	1,164	8,289	$2,023,895
2023	1,226	5,222	$1,167,001
2024	1,312	5,452	$1,159,921

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	253	399	$10,913
2016	335	475	$13,892
2017	405	586	$11,745
2018	541	830	$19,210
2019	697	1,066	$21,458
2020	510	700	$13,436
2021	385	502	$10,326
2022	389	515	$9,427
2023	1,108	1,533	$26,178
2024	1,303	1,770	$25,545

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	867	1,102	$388
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	258	379	$299
13132	Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm	376	423	$109
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	303	303	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	370	489	$63

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Doxycycline Hyclate	Doxycycline Hyclate	1,460	15,060	$14,538
Fluorouracil	Fluorouracil	52	1,543	$3,580
Clobetasol Propionate	Clobetasol Propionate	22	576	$663
Triamcinolone Acetonide	Triamcinolone Acetonide	30	1,144	$260
Doxycycline Monohydrate	Doxycycline Monohydrate	20	200	$228

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$23	MIMEDX Group, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas Lewis Hamaguchi Hocker, M.D.?

Tedicare shows public-source Medicare data for Thomas Lewis Hamaguchi Hocker, M.D. (NPI 1689841025), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Lewis Hamaguchi Hocker, M.D. have ACO affiliation data?

Thomas Lewis Hamaguchi Hocker, M.D. is shown with ACO affiliation data for Centrus Health LLC (MSSP, ACO ID A5304) and Centrus Health of Kansas LLC (MSSP, ACO ID A5305).

What billing organization is linked to Thomas Lewis Hamaguchi Hocker, M.D.?

Thomas Lewis Hamaguchi Hocker, M.D. is linked to ADVANCED DERMATOLOGIC SURGERY, P.A. (billing NPI 1003016312) in the available physician profile data.

Does Thomas Lewis Hamaguchi Hocker, M.D. have Open Payments data?

Thomas Lewis Hamaguchi Hocker, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.